Immunis to use MRI-based AI muscle analysis for sarcopenia trial
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…
Ariceum Therapeutics has initiated a Phase I trial for iodine-123 labelled ¹²³I-ATT001 in brain cancer patients, as the company eyes…
Spectral AI has added three clinical trials for a US pivotal study evaluating its AI-based diagnostics platform DeepView. The addition…
Jaguar Health said an initial analysis of anti-diarrhoeal drug Mytesi (crofelemer) in cancer patients showed the Phase III trial did…
IceCure Medical has reported data from three clinical trials, showcasing the efficacy of its ProSense cryoablation device in the treatment…
With the addition of New York’s Memorial Sloan Kettering Cancer Center, Microbot has completed enrolment of clinical sites in a…
Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building that…
SPR Therapeutics has reported positive long-term data for its SPRINT PNS pain management system, as well as primary endpoint results…
Six months after winning fast track status for multiple sclerosis, Kyverna Therapeutics’ KYV-101 has secured another US Food and Drug…
The US Food and Drug Administration (FDA) has approved Artelo Biosciences’ investigational new drug (IND) application, greenlighting a Phase I…